Citigroup’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,222
| Closed | -$16K | – | 5434 |
|
|
2022
Q2 | $16K | Buy |
2,222
+2,155
| +3,216% | +$15.5K | ﹤0.01% | 4428 |
|
|
2022
Q1 | $1K | Buy |
+67
| New | +$1K | ﹤0.01% | 5388 |
|
|
2021
Q4 | – | Sell |
-161
| Closed | -$4K | – | 5251 |
|
|
2021
Q3 | $4K | Sell |
161
-12
| -7% | -$298 | ﹤0.01% | 4855 |
|
|
2021
Q2 | $11K | Sell |
173
-8,114
| -98% | -$516K | ﹤0.01% | 4957 |
|
|
2021
Q1 | $1.02M | Buy |
8,287
+7,833
| +1,725% | +$965K | ﹤0.01% | 2369 |
|
|
2020
Q4 | $52K | Buy |
454
+357
| +368% | +$40.9K | ﹤0.01% | 4080 |
|
|
2020
Q3 | $12K | Sell |
97
-101
| -51% | -$12.5K | ﹤0.01% | 4226 |
|
|
2020
Q2 | $25K | Sell |
198
-10
| -5% | -$1.26K | ﹤0.01% | 4115 |
|
|
2020
Q1 | $40K | Buy |
208
+158
| +316% | +$30.4K | ﹤0.01% | 3956 |
|
|
2019
Q4 | $17K | Buy |
50
+30
| +150% | +$10.2K | ﹤0.01% | 4546 |
|
|
2019
Q3 | $7K | Sell |
20
-35
| -64% | -$12.3K | ﹤0.01% | 4693 |
|
|
2019
Q2 | $24K | Buy |
55
+22
| +67% | +$9.6K | ﹤0.01% | 4509 |
|
|
2019
Q1 | $19K | Sell |
33
-3
| -8% | -$1.73K | ﹤0.01% | 4551 |
|
|
2018
Q4 | $10K | Sell |
36
-1
| -3% | -$278 | ﹤0.01% | 4632 |
|
|
2018
Q3 | $26K | Buy |
37
+19
| +106% | +$13.4K | ﹤0.01% | 4421 |
|
|
2018
Q2 | $10K | Buy |
18
+6
| +50% | +$3.33K | ﹤0.01% | 4623 |
|
|
2018
Q1 | $32K | Buy |
+12
| New | +$32K | ﹤0.01% | 3999 |
|